Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Parallel Clinical Study to Determine the Safety and Tolerability of a Range of Doses of PeptiControl in Pre-diabetic Individuals.

NCT06440213 is registered in ClinicalTrials.gov with Nuritas Ltd as lead sponsor.

NCT NCT06440213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06440213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Parallel Clinical Study to Determine the Safety and Tolerability of a Range of Doses of PeptiControl in Pre-diabetic Individuals.
Lead sponsor
Nuritas Ltd
Phase
Not applicable
Overall status
Completed
Start date
May 20, 2024
Completion date
February 1, 2025
Enrollment
132 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

overweight, pre diabetes